From: Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review
Imaging modality | Sen (95%CI) | Spe (95%CI) | DOR (95%CI) | |
---|---|---|---|---|
Liver metastasis | US | 0.54 (0.34-0.73) | 0.98 (0.90-0.99) | 50.25 (13.48-187.32) |
 | CT | 0.74 (0.59-0.85) | 0.99 (0.97-1.00) | 251.14 (83.53-755.07) |
 | PET | 0.70 (0.36-0.90) | 0.96 (0.81-0.99) | 56.46 (8.47-376.23) |
Peritoneal metastasis | US | 0.09 (0.03-0.21) | 0.99 (0.96-1.00) | 10.63 (1.54-73.36) |
 | EUS | 0.34 (0.10-0.69) | 0.96 (0.87-0.99) | 13.07 (6.42-26.62) |
 | CT | 0.33 (0.16-0.56) | 0.99 (0.98-1.00) | 66.18 (27.28-160.53) |
 | PET | 0.28 (0.17-0.44) | 0.97 (0.83-1.00) | 12.49 (2.22-70.10) |